Role of Metabolic Syndrome in Global CVD Risk Assessment
Proceedings of the 3rd Bi-Annual Meeting of the International Chair on
Cardiometabolic Risk
New York, December 16th, 2006
Guest Editor:
Dr Jean-Pierre Despr�s
TABLE OF CONTENTS
Volume 32, Issue S2 (May 2008)
Top of page
Top of page
Editorial
CVD risk assessment: do we need the metabolic syndrome or better global cardiometabolic risk calculators?
J-P Després
Int J Obes 32: S1-S4; doi:10.1038/ijo.2008.27
Original Articles
The metabolic syndrome and cardiovascular risk: implications for clinical practice
D M Eddy, L Schlessinger and K Heikes
Int J Obes 32: S5-S10; doi:10.1038/ijo.2008.28
Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study
G Assmann, H Schulte and U Seedorf
Int J Obes 32: S11-S16; doi:10.1038/ijo.2008.29
Cardiometabolic risk: a Framingham perspective
P W F Wilson and J B Meigs
Int J Obes 32: S17-S20; doi:10.1038/ijo.2008.30
Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study
C M Ballantyne, R C Hoogeveen, A M McNeill, G Heiss, M I Schmidt, B B Duncan and J S Pankow
Int J Obes 32: S21-S24; doi:10.1038/ijo.2008.31
The metabolic syndrome and cardiovascular risk in the British Regional Heart Study
S G Wannamethee
Int J Obes 32: S25-S29; doi:10.1038/ijo.2008.32
